Shopping Cart
- Remove All
- Your shopping cart is currently empty
EGFR-IN-112 (SPP10), an EGFR kinase inhibitor, displays IC50 values of 2.31 ± 0.3 μM for MCF-7, 3.16 ± 0.8 μM for H69AR, and 4.2 ± 0.2 μM for PC-3 cancer cells, showcasing selective cytotoxicity towards these cancer cell lines.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | EGFR-IN-112 (SPP10), an EGFR kinase inhibitor, displays IC50 values of 2.31 ± 0.3 μM for MCF-7, 3.16 ± 0.8 μM for H69AR, and 4.2 ± 0.2 μM for PC-3 cancer cells, showcasing selective cytotoxicity towards these cancer cell lines. |
In vitro | EGFR-IN-112 (IC 50, 72 h) significantly inhibits Bcl-2 in MCF-7, H69AR, and PC-3 cells, while simultaneously inducing Bax and Cyt-c [1]. |
Molecular Weight | 421.56 |
Formula | C27H23N3S |
Cas No. | 2758436-98-3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.